Print Page     Close Window     

SEC Filings

10-K
SERES THERAPEUTICS, INC. filed this Form 10-K on 03/06/2019
Entire Document
 

 

 

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

 

SERES THERAPEUTICS, INC.

 

 

 

 

 

Date: March 6, 2019

 

By:

 

/s/ Eric D. Shaff

 

 

 

 

Eric D. Shaff

 

 

 

 

President, Chief Executive Officer and Director

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

Signature

 

Title

 

Date

 

 

 

 

 

/s/ Eric D. Shaff

 

President, Chief Executive Officer

 

March 6, 2019

Eric D. Shaff

 

and Director

 

 

 

 

(Principal Executive Officer and Principal Financial and Accounting Officer)

 

 

 

 

 

 

 

/s/ Roger J. Pomerantz

 

Chairman of the Board

 

March 6, 2019

Roger J. Pomerantz, M.D.

 

 

 

 

 

 

 

 

 

/s/ Noubar B. Afeyan

 

Director

 

March 6, 2019

Noubar B. Afeyan, Ph.D.

 

 

 

 

 

 

 

 

 

/s/ Dennis Ausiello

 

Director

 

March 6, 2019

Dennis Ausiello, M.D.

 

 

 

 

 

 

 

 

 

/s/ Willard Dere

 

Director

 

March 6, 2019

Willard Dere

 

 

 

 

 

 

 

 

 

/s/ Grégory Behar

 

Director

 

March 6, 2019

Grégory Behar

 

 

 

 

 

 

 

 

 

/s/ Kurt C. Graves

 

Director

 

March 6, 2019

Kurt C. Graves

 

 

 

 

 

 

 

 

 

/s/ Richard N. Kender

 

Director

 

March 6, 2019

Richard N. Kender

 

 

 

 

 

 

 

 

 

/s/ Lorence H. Kim

 

Director

 

March 6, 2019

Lorence H. Kim, M.D.

 

 

 

 

 

 

 

 

 

/s/ Meryl Zausner

 

Director

 

March 6, 2019

Meryl Zausner

 

 

 

 

 

 

 

 


© Seres Therapeutics. All Rights Reserved.